{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:00:27Z","timestamp":1761580827564},"reference-count":31,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1507\/endocrj.k10e-258","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T05:20:17Z","timestamp":1287724817000},"page":"1045-1054","source":"Crossref","is-referenced-by-count":23,"title":["Localization of medullary thyroid carcinoma after surgery using 11C-methionine PET\/CT: comparison with 18F-FDG PET\/CT"],"prefix":"10.1507","volume":"57","author":[{"given":"Hye Won","family":"Jang","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji In","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Won","family":"Shin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hee","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hoon","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. <i>Cancer<\/i> 88: 1139-1148.","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stepanas AV, Samaan NA, Hill CS, Jr., Hickey RC (1979) Medullary thyroid carcinoma: importance of serial serum calcitonin measurement. <i>Cancer<\/i> 43: 825-837.","DOI":"10.1002\/1097-0142(197903)43:3<825::AID-CNCR2820430308>3.0.CO;2-Q"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fugazzola L, Pinchera A, Luchetti F, Iacconi P, Miccoli P, Romei C, Puccini M, Pacini F (1994) Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma. <i>Int J Biol Markers<\/i> 9: 21-24.","DOI":"10.1177\/172460089400900104"},{"key":"4","unstructured":"4. Clarke SE, Lazarus CR, Wraight P, Sampson C, Maisey MN (1988) Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. <i>J Nucl Med<\/i> 29: 33-38."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Berna L, Cabezas R, Mora J, Torres G, Estorch M, Carrio I (1995) 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. <i>J Endocrinol<\/i> 144: 339-345.","DOI":"10.1677\/joe.0.1440339"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Krausz Y, Rosler A, Guttmann H, Ish-Shalom S, Shibley N, Chisin R, Glaser B (1999) Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid. <i>Clin Nucl Med<\/i> 24: 256-260.","DOI":"10.1097\/00003072-199904000-00008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Adams S, Baum RP, Hertel A, Schumm-Draeger PM, Usadel KH, Hor G (1998) Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. <i>Eur J Nucl Med <\/i>25: 1277-1283.","DOI":"10.1007\/s002590050296"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. de Groot JW, Links TP, Jager PL, Kahraman T, Plukker JT (2004) Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. <i>Ann Surg Oncol<\/i> 11: 786-794.","DOI":"10.1245\/ASO.2004.10.015"},{"key":"9","unstructured":"9. Szakall S, Jr., Esik O, Bajzik G, Repa I, Dabasi G, Sinkovics I, Agoston P, Tron L (2002) 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. <i>J Nucl Med<\/i> 43: 66-71."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, Lange H, Bredow J, Korber C, Grunwald F (2001) Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. <i>Eur J Nucl Med<\/i> 28: 1671-1676.","DOI":"10.1007\/s002590100614"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rubello D, Rampin L, Nanni C, Banti E, Ferdeghini M, Fanti S, Al-Nahhas A, Gross MD (2008) The role of 18F-FDG PET\/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study. <i>Eur J Surg Oncol<\/i> 34: 581-586.","DOI":"10.1016\/j.ejso.2007.08.005"},{"issue":"8","key":"12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1349-7006.1989.tb01714.x","volume":"80","author":"KUBOTA K","year":"1989","ISSN":"http:\/\/id.crossref.org\/issn\/0910-5050","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hoffman RM (1984) Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. <i>Biochim Biophys Acta <\/i>738: 49-87.","DOI":"10.1016\/0304-419X(84)90019-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jana S, Blaufox MD (2006) Nuclear medicine studies of the prostate, testes, and bladder. <i>Seminars in Nuclear Medicine<\/i> 36: 51-72.","DOI":"10.1053\/j.semnuclmed.2005.09.001"},{"issue":"5","key":"15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0360-3016(94)90328-X","volume":"30","year":"1994","ISSN":"http:\/\/id.crossref.org\/issn\/0360-3016","issn-type":"print"},{"key":"16","unstructured":"16. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA (2001) Radiolabeled amino acids: basic aspects and clinical applications in oncology. <i>J Nucl Med <\/i>42: 432-445."},{"key":"17","unstructured":"17. Leskinen-Kallio S, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M, Joensuu H (1992) Carbon-11-methionine and PET is an effective method to image head and neck cancer. <i>J Nucl Med<\/i> 33: 691-695."},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-007-0142-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wieder H, Ott K, Zimmermann F, Nekarda H, Stollfuss J, Watzlowik P, Siewert JR, Fink U, Becker K, Schwaiger M, Weber WA (2002) PET imaging with [11C]methyl- L-methionine for therapy monitoring in patients with rectal cancer. <i>European Journal of Nuclear Medicine and Molecular Imaging<\/i> 29: 789-796.","DOI":"10.1007\/s00259-002-0779-4"},{"key":"20","unstructured":"20. Nunez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM (2002) Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. <i>J Nucl Med<\/i> 43: 46-55."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lindholm P, Lapela M, Nagren K, Lehikoinen P, Minn H, Jyrkkio S (2009) Preliminary study of carbon-11 methionine PET in the evaluation of early response to therapy in advanced breast cancer. <i>Nucl Med Commun<\/i> 30: 30-36.","DOI":"10.1097\/MNM.0b013e328313b7bc"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Phan HT, Jager PL, Plukker JT, Wolffenbuttel BH, Dierckx RA, Links TP (2008) Comparison of 11C-methionine PET and 18F-fluorodeoxyglucose PET in differentiated thyroid cancer. <i>Nucl Med Commun<\/i> 29: 711-716.","DOI":"10.1097\/MNM.0b013e328301835c"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. HW Jang, JI Lee, KY Hur, JH Kim, SW Kim, YK Min, MS Lee, MK Lee, KW Kim, JH Chung (2010) Clinicopathological characteristics and prognostic factors of medullary thyroid carcinoma. <i>Endocrinol Metab <\/i>25: 183-191.","DOI":"10.3803\/EnM.2010.25.3.183"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, van der Horst-Schrivers AN, Jager PL (2006) Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. <i>Lancet Oncology<\/i> 7: 728-734.","DOI":"10.1016\/S1470-2045(06)70801-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Koopmans KP, de Groot JW, Plukker JT, de Vries EG, Kema IP, Sluiter WJ, Jager PL, Links TP (2008) 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.<i> J Nucl Med<\/i> 49: 524-531.","DOI":"10.2967\/jnumed.107.047720"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Laure Giraudet A, Al Ghulzan A, Auperin A, Leboulleux S, Chehboun A, Troalen F, Dromain C, Lumbroso J, Baudin E, Schlumberger M (2008) Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. <i>Eur J Endocrinol<\/i> 158: 239-246.","DOI":"10.1530\/EJE-07-0667"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Giraudet AL, Vanel D, Leboulleux S, Auperin A, Dromain C, Chami L, Ny Tovo N, Lumbroso J, Lassau N, Bonniaud G, Hartl D, Travagli JP, Baudin E, Schlumberger M (2007) Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. <i>J Clin Endocrinol Metab<\/i> 92: 4185-4190.","DOI":"10.1210\/jc.2007-1211"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ong SC, Schoder H, Patel SG, Tabangay-Lim IM, Doddamane I, Gonen M, Shaha AR, Tuttle RM, Shah JP, Larson SM (2007) Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. <i>J Nucl Med<\/i> 48: 501-507.","DOI":"10.2967\/jnumed.106.036681"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Grunwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, Palmedo H, Ruhlmann J, Kozak B, Biersack HJ (1996) Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. <i>Eur J Nucl Med<\/i> 23: 312-319.","DOI":"10.1007\/BF00837630"},{"issue":"7","key":"30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00006231-199807000-00005","volume":"19","author":"ADAMS S","year":"1998","ISSN":"http:\/\/id.crossref.org\/issn\/0143-3636","issn-type":"print"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Busnardo B, Girelli ME, Simioni N, Nacamulli D, Busetto E (1984) Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. <i>Cancer<\/i> 53: 278-285.","DOI":"10.1002\/1097-0142(19840115)53:2<278::AID-CNCR2820530216>3.0.CO;2-Z"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/12\/57_K10E-258\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:54:48Z","timestamp":1618296888000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/12\/57_K10E-258\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-258","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}